Role of interleukin-6 in macrophage function

Current Opinion in Hematology

Volumn 3, Issue 1, 1996, Pages 87-93

  Akira, Shizuo ^a   Kishimoto, Tadamitsu ^b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

CELL SPECIFICITY; GENE CONTROL; GENE EXPRESSION; HUMAN; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW;

EID: 0029893140     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603010-00013     Document Type: Review

References (65)

1. Akira S, Taga T, Kishimoto T: Interteukin-6 in biology and medicine. Adv Immunol 1993, 54:1-78.
2. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 1994, 76:253-262. A comprehensive review of cytokine signaling from the receptor to the nucleus.
3. Jilka RL, Hangoc G, Girasole G, Rasseri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: mediation by interieukin-6. Science 1992, 257:88-91.
4. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F: IL-6 deficient mice are protected from bone loss by estrogen depletion. EMBO J 1994, 13:1189-1196. This report shows that interleukin-6 is essential for the bone loss caused by estrogen deficiency.
5. Kopf M, Bauman H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethamann H, Kohler G: Impaired immune and acute-phase responses in IL-6-deficient mice. Nature 1994, 368:339-342. A first report demonstrating the interleukin-6 knockout mice have several abnormalities in immune and acute-phase responses.
6. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M: The role of interieukin-6 in mucosal IgA antibody responses in vivo. Science 1994, 264:561-563.
7. Hilbert DM, Kopf K, Mock BA, Kohler G, Rudikoff S: Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med 1995, 182:243-248.
8. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, Poli V: Defective inflammatory response in IL-6-deficient mice. J Exp Med 1994, 180:1243-1250.
9. Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, Lee F, Murray R: Interteukin-6 deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995, 63:2262-2268.
10. Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC: Interteukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1994, 1:725-731.
11. Zhang Y, Broser M, Rom WN: Activation of the IL-6 gene by mycobacterium tuberculosis or LPS is mediated by nuclear factors NF-IL6 and NF-κ B. Proc Natl Acad Sci U S A 1994, 91:2225-2229.
12. Dendorfer U, Oettgen P, Libermann TA: Multiple regulatory elements in the IL-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 1994, 14:4443-4454.
13. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990, 9:1897-1906.
14. Poli V, Mancini FP, Cortese R: II-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 1990, 63:643-653.
15. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552.
16. Akira S, Kishimoto T: II-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992, 127:25-50.
17. Bretz JD, Williams SC, Baeir M, Johnson PF, Schwartz RC: C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Natl Acad Sci U S A 1994, 91:7306-7310.
18. Kiehntopf M, Herrmann F, Brach MA: Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts. J Exp Med 1995, 181:793-798.
19. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995, 80:353-361. The NF-IL6 knockout mice demonstrates that NF-IL6 is essential for bactericidal and tumoricidal activities by macrophages. This study also shows that NF-IL6 is not essential for several cytokines except for G-CSF, the expression of which has been considered to be mediated by NF-IL6.
20. Burk O, Mink S, Ringwald M, Klempnauer K-H: Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 1993, 12:2027-2038.
21. Katz S, Kowenz LE, Muller C, Meese K, Ness SA, Leutz A: The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J 1993, 12:1321-1332.
22. Ness SA, Kowenz LE, Casini T, Graf T, Leutz A: Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 1993, 7:749-759.
23. Kowen-Leutz E, Twamley G, Ansieau S, Leutz A: Novel mechanism of C/EBPβ (NF-M transcriptional control: activation through derepression. Genes Dev 1994, 8:2781-2791. Demonstrates that activation of signaling pathways results in pbosphorylation of the inhibitory domains of NF-IL6(C/EBPβ), thereby abrogating the inhibition by exposing its trans-activating functions.
24. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S: Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A 1993, 90:2207-2211.
25. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of NF-κB-and C/EBP-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines. J Biol Chem 1990, 265:21128-21133.
26. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P: The role of NF-κ B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by IL-1 and IL-6. J Biol Chem 1993, 268:25624-25631.
27. Li X, Liao WSL: Cooperative effects of C/EBP-like and NF-κ B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res 1992, 20:4765.
28. Brasier AR, Ron D, Tate JE, Habener JF: A family of constitutive C/EBP-like DNA binding proteins stimulate the IL-1a induced, NF-κ B mediated transactivation of the angiotensinogen gene acute-phase response element. EMBO J 1990, 9:3933-3944.
29. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF: Requirement for NF-κ B p65 and NF-IL6 binding elements in the TNF response region of the G-CSF promoter. Blood 1994, 83:2469-2479.
30. Hou J, Baichwal V, Cao Z: Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1994, 91:11641-11645.
31. LeClair KP, Blanar MA, Sharp PA: The p50 subunit of NF-κ B associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 1992, 89:8145-8149.
32. Stein B, Cogswell PC, Baldwin AS: Functional and physical associations between NF-κ B and C/EBP family member: a Rel domain-bZIP interaction. Mol Cell Biol 1993, 13:3964-3974.
33. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL6 and NF-κ B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interteukin 8. Proc Natl Acad Sci U S A 1993, 90:10193.
34. Kunsch C, Lang RK, Rosen CA, Shannon MF: Synergistic transcriptional activation of the IL-8 gene by NF-κ B p65 (RelA) and NF-IL6. J Immunol 1994, 153:153-164.
35. Ray A, LaForge KS, Sehgal PB: Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary? Proc Natl Acad Sci U S A 1991, 88:7086-7090.
36. Ray A, Prefontaine KE, Ray P: Down-modulation of interieukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994, 269:12940-12946.
37. Stein B, Yang MR: Repression of the interieukin-6 promoter by estrogen receptor is mediated by NF-κ B and C/EBPβ. Mol Cell Biol 1995, 15:4971-4979.
38. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-κ B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1994, 91:752-756.
39. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS: Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptor. Mol Cell Biol 1995, 15:943-953.
40. Darnell JE, Kerr IM, Stark GR: JAK-STAT pathways and transcriptional activation in response to interferons and other extracellular signaling proteins. Science 1994, 264:1415-1421. An authoritative review of Jak-STAT pathways by a pioneer group.
41. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994, 19:222-227. An excellent and concise review of Jak-STAT pathways in cytokine signaling.
42. Lütticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T, Kishimoto T, Barbieri G, Pellegrini S, Sendtner M, Heinrich PC, Horn F: Association of transcription factor APRF and protein kinase Jak1 with the IL-6 signal transducer gp130. Science 1994, 263:89-92.
43. Narazaki M, Witthuhn BA, Yoshida K, Silvennoinen O, Yasukawa K, Ihle JN, Kishimoto T, Taga T: Activation of JAK2 kinase mediated by the interteukin 6 signal transducer gp130. Proc Natl Acad Sci U S A 1994, 91:2285-2289.
44. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994, 77:63-71. With the paper by Zhong et al. (Science 1994, 264:95-98), this paper provides first convincing evidence that cytokines other than interferons use a novel STAT family member as well as the similar Jak-STAT signaling pathway that interferons do. These papers suggest differential use of STAT family members may explain the functional diversity exerted by individual cytokines.
45. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994, 77:63-71. With the paper by Zhong et al. (Science 1994, 264:95-98), this paper provides first convincing evidence that cytokines other than interferons use a novel STAT family member as well as the similar Jak-STAT signaling pathway that interferons do. These papers suggest differential use of STAT family members may explain the functional diversity exerted by individual cytokines.
46. Zhong Z, Wen Z, Darnell JE Jr: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interieukin-6. Science 1994, 264:95-98. With the paper by Akira et al. (Cell 1994, 77:63-71), this paper provides first convincing evidence that cytokines other than interferons use a novel STAT family member as well as the similar Jak-STAT signaling pathway that interferons do. These papers suggest differential use of STAT family members may explain the functional diversity exerted by individual cytokines.
47. Zhong Z, Wen Z, Darnell JE Jr: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interieukin-6. Science 1994, 264:95-98. With the paper by Akira et al. (Cell 1994, 77:63-71), this paper provides first convincing evidence that cytokines other than interferons use a novel STAT family member as well as the similar Jak-STAT signaling pathway that interferons do. These papers suggest differential use of STAT family members may explain the functional diversity exerted by individual cytokines.
48. Tian S-S, Lamb P, Seidel HM, Stein RB, Rosen J: Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 1994, 84:1760-1764.
49. Greenlund AC, Farrar MA, Viviano BL, Schreiber RD: Ligand induced IFNγ receptor phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 1994, 13:1591-1600.
50. Hou J, Schindler U, Henzel WJ, Ho T, Brasseur M, McKnight SL: An Interteukin-4-induced transcription factor: IL-4 Stat. Science 1994, 265:1701-1706.
51. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD: Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995, 267:1349-1353. This paper demonstrates that a consensus sequence YXXQ present in the signal transducing receptor components is necessary and sufficient for tyrosine phosphorylation of STAT3.
52. Seidel HM, Molocco JH, Lamb P, Darnell JE, Stein RB, Rosen J: Spacing of palindromic half sites as a determinant of selective STAT DNA binding and transcriptional activity. Proc Natl Acad Sci U S A 1995, 92:3041-3045.
53. Horvath CM, Wen Z, Darnell JE Jr: A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995, 9:984-994. Reports the location of the DNA binding domain of STAT proteins.
54. Schindler U, Wu P, Rothe M, Brasseur M, Mcknight SL: Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995, 2:689-697. Reports the location of the DNA binding domain of STAT proteins.
55. Zhang X, Belnis J, Li H-C, Schindler C, Chen-Kiang S: Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995, 264:1990-1994.
56. Wen Z, Zhong Z, Darnell JE: Maximal activation of transcription by Stal1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250. Shows that full transcriptional activation by STAT1 and STAT3 requires serine phosphorylation at the C-terminus, besides obligatory requirement of tyrosine phosphorylation of dimerization, translocation to the nucleus, and DNA binding.
57. Nakajima K, Wall R: Interleukin-6 signals activating junB and TIS 11 gene transcription in a B-cell hybridoma. Mol Cell Biol 1991, 11:1409-1418.
58. Boulton TG, Shong Z, Wen Z, Darnell JE, Stahl N, Yancopoulos GD: STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci U S A 1995, 92:6915-6919.
59. Kaufmann SHE: Immunity to intracellular bacteria. Annu Rev Immunol 1993, 11:129-163.
60. Nathan CF, Hibbs JM: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991, 3:65-70.
61. Martin E, Nathan C, Xie Q-W: Role of interferon regulatory factor 1 in induction of nitric oxide synthese. J Exp Med 1994, 180:977-984.
62. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Im KS, Kimura T, Green S, et al.: Requirements for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994, 263:1612-1615. This paper demonstrates that interferon regulatory factor 1 is essential for nitrous oxide synthase induction in macrophages.
63. MacMicking JD, Nathan C, Horn G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al.: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650. Describes the phenotype of mice lacking inducible nitric oxide synthase.
64. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Costantini F, Poli V: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice. EMBO J 1995, 14:1932-1941. Demonstrates that NF-IL6 (C/EBPβ) knockout mice develop a systemic Castleman's disease-like phenotype with age.
65. Uematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A 1989, 86:7547-7551.